A Single-arm, Multicenter, Phase II Clinical Study of Camrelizumab Combined With Famitinib in Adjuvant Therapy After Radical Resection of Cervical Cancer
Fudan University
Fudan University
M.D. Anderson Cancer Center
Washington University School of Medicine
University of Cincinnati
Kaiser Permanente
UNC Lineberger Comprehensive Cancer Center
Taipei Veterans General Hospital, Taiwan
University of Florida
University of Rochester
Obstetrics & Gynecology Hospital of Fudan University
George Washington University
Tulane University
Seoul National University Hospital
Massachusetts General Hospital
Boston Medical Center
University of Arizona
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Boston University Charles River Campus
Centre Hospitalier Intercommunal Creteil
International Agency for Research on Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
University of Sunderland
Ordu University
University of Virginia
Obstetrics & Gynecology Hospital of Fudan University
IRCCS Azienda Ospedaliero-Universitaria di Bologna
University Hospital, Ghent
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Peking Union Medical College Hospital
Ordu University
GICMED
Chang Gung Memorial Hospital
Tongji Hospital